Viewing Study NCT02997761


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2026-01-02 @ 3:27 PM
Study NCT ID: NCT02997761
Status: RECRUITING
Last Update Posted: 2024-05-29
First Post: 2016-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia
Sponsor: Brian Jonas
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult B Acute Lymphoblastic Leukemia View
None Philadelphia Chromosome Positive View
Keywords: